Using Modern Imaging Technology

Learn More

With new, proprietary drug formulations

Learn More

To precisely treat late stage and metastatic cancer

Learn More

and to stimulate a natural, adaptive immune response.

Learn More

Intensity Therapeutics is creating a new, highly effective cancer treatment - in situ vaccination.

Learn More

Intensity Therapeutics


Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to greatly extend the lives of patients with cancer.  The Company’s proprietary DfuseRxSM platform technology creates novel immune-based therapeutic products that can directly kill tumors and stimulate a strong adaptive immune response in certain cancer types.  This approach is a new and emerging field of cancer treatment known as in situ vaccination.    


Who we are

Intensity Therapeutics is a clinical development stage company.  We are seeking partnerships/investors interested in advancing the company’s anti-cancer platform technology and lead product INT230-6. 


Learn more

Contact Us

Intensity Therapeutics, Inc.
61 Wilton Road, 3rd Floor
Westport, CT 06880

Tel. (203) 221-7377
Fax (203) 664-1051


Click here for career inquiries

A video about Intensity's Science